Libity

For investors tracking redemption windows and sponsor conduct, the filing crystallizes a fixed redemption execution window closing at 5:00 P.M. ET on May 12, 2026 and anchors the ultimate liquidation horizon to May 12, 2028. Because the Company asserts that Cayman Islands law permits proceeding without a public proxy solicitation, the governance changes will execute based on consent from the controlling block, insulating management from a direct public referendum on the extended timeline. The Registrant’s ownership table discloses that as of April 28, 2026, there were 6,494,831 ordinary shares outstanding, with Vikas Mittal (acting through Samara Special Opportunities) beneficially owning 65.0% and the former Sponsor, ICE I Holdings Pte. Ltd., holding 29.9%. Beyond these governance mechanics, the proposed rebrand to Libity, and the explicit reservation of up to US $100,000 of interest for dissolution costs, the Company makes no claims regarding target pipeline progress, projected revenues, market size, technology developments, customer partnerships, or litigation status.

This is the definitive deal announcement for IVCA. Key for investors: (1) Redemption risk — public shareholders can redeem at the closing; trust per share is $12.84, above the $10.00 stated value, so there is potential for redemptions. Sponsor has agreed not to redeem and to cancel its private warrants, which is a positive signal and reduces dilution. (2) Target — Blue Finance is a UK-based digital lender (My Finance Club) with FCA authorization, requiring regulatory approval, which adds execution risk. (3) Structure — New Pubco will be an Irish public company listed on Nasdaq, so there are Irish corporate and tax complexities. (4) Earnout — performance-based shares up to 6M shares, which could drive additional dilution if milestones are met. (5) Sponsor conduct — sponsor agreed to cancel all private warrants (11.26M), which is a significant concession and aligns interests. (6) Deadline — the 2028 deadline is unusually long, likely from prior extensions; the deal has a firm outside date of November 4, 2026, and a hard drop-dead of December 1, 2026. (7) Trust value — $12.84/share is above the $10 stated value, so there may be incentive for redemptions. (8) Financials — Blue Finance's unaudited financials show 2025/2024 data; no PCAOB audited statements yet, but the agreement requires audited 2024 financials by April 30, 2026 and 2025 by May 31, 2026, which are conditions precedent.

This is the first definitive deal agreement for IVCAF, which has a trust per-share value of $12.84 and a deadline of May 12, 2028. Investors should note: (1) the trust value is well above the conventional $10.00 – at $12.84/share the implied redemption pressure could be different than typical SPACs; (2) the sponsor has agreed to not redeem and to cancel its private warrants, which removes a large overhang; (3) the earnout structure is complex and subject to Irish Takeover Rules restructuring risk, with a termination right if parties cannot agree on the earnout structure; (4) the SPAC's securities trade on OTC Markets and the target is going public via an Irish plc structure; (5) FCA approval for change of control is a closing condition, adding a regulatory risk factor not present in domestic deals; (6) Blue Finance is an AI-driven UK consumer lender having originated over $200 million in loans.

Because the Purchase Agreement transfers control for $1.00 before any business combination announcement, future redemption votes, extension approvals, and trust fund usage are now directed by the Acquirer rather than the founding sponsor. The explicit waiver in Section 14(c) stating the Acquirer assumes liquidation risk and the Seller forfeits claims related to failed combinations fundamentally alters the traditional redemption-calculus and sponsor conduct landscape. The compressed September 1, 2025 termination window starkly contrasts with the May 12, 2027 contractual deadline, pressuring rapid deal execution or alternative liquidity arrangements. Sponsor retention of over 1.9 million shares and nearly 4.8 million warrants without matching forfeiture safeguards preserves significant post-combination equity upside for the original sponsor, potentially influencing voting dynamics. With no trust balance disclosed and all ongoing administrative, legal, and accounting expenses mandated to be funded by the Acquirer, shareholders must reassess baseline redemption expectations and monitor the incoming board’s integration timeline, registration rights joinder, and upcoming name-change vote for further mechanical triggers.

This filing documents a third-party take-control transaction that fundamentally alters the SPAC's trajectory and sponsor dynamics. The acquisition of 69.7% of public shares by Samara Special Opportunities/Vikas Mitta suggests a concentrated shareholder base that can exert significant pressure on management regarding business combination strategy or redemption outcomes. The resignation of the entire incumbent board removes the previous Investcorp-affiliated leadership structure. Financial disclosures reveal heavy reliance on sponsor funding and extensions: outstanding working capital loans totaled $2,836,172 as of June 30, 2025, and extension contribution notes reached a principal balance of $1,650,000 by the same date. Subsequent to June 30, 2025, the Company satisfied approximately $6.2 million in liabilities, including a $4.9 million write-off of liabilities owed to the Sponsor. These figures indicate extensive liquidity support and potential forgiveness to keep the entity solvent. The extension notes are payable no earlier than May 12, 2027, confirming an extended timeline past the original period. Governance risks persist as the Company maintains no audit, nominating, or compensation committees due to its OTC Pink listing status, leaving all board functions to the directors. No business combination target is identified in this filing.

This filing confirms that IVCAF has secured a two-year extension to its deadline, but at the cost of near-total redemptions: only 26,021 of the initial 1,475,380 shares remained in trust as of June 30, 2025. With a trust account of less than $500,000 and a reported working capital deficit, the SPAC is effectively stripped of the capital needed to complete an acquisition. The Company disclosed a material weakness in internal controls and raised substantial doubt about its ability to continue as a going concern. The delisting to OTC Markets further limits the potential for a business combination.

Per The Nasdaq Stock Market, LLC's determinations, stripping Nasdaq listing status during an active business combination phase forces secondary trading to alternative venues, which typically thickens bid-ask spreads and delays execution around any redemption or conversion windows. Because the Exchange tied the action to Listing Rule IM-5101-2(b) rather than a failed transaction, shareholder liquidity is restricted pending resolution of the announced deal or expiration of the 2028-05-12 deadline, compounding uncertainty around trust preservation and exit timing.

The near-total redemption of public shares and Nasdaq delisting fundamentally alter the SPAC's prospects. With only ~26,000 public shares remaining and trust proceeds essentially gone, the sponsor (ICE I Holdings) now controls virtually all voting power through its 6,468,749 Class A (converted from Class B) shares. The company will struggle to attract a target without meaningful cash in trust and with reduced market visibility on OTC. The extension to 2027 provides time, but the economics of any potential deal would rely almost entirely on sponsor equity or new financing. The delisting heightens risk of further liquidity deterioration. Investors face heightened risk of liquidation if no business combination is consummated.

Per the disclosed mechanics, securing a twenty-four-month extension immediately removes the imminent liquidation clock, granting the sponsor and management team additional operational runway to identify, negotiate, and close a qualifying target without triggering automatic trust dissolution. The documented $17,521,050 redemption outflow permanently reduces remaining net asset value, tightening future liquidity parameters for warrant exercises, working capital needs, or fund financing relative to pre-vote balances. Near-universal proxy engagement (89.32%) and a decisive shareholder majority indicate robust institutional and retail consensus behind the continuation strategy rather than a flight-to-cash revolt. The Kapoor and Bahl director appointments reflect routine board rotation rather than strategic leadership overhauls, while the CBIZ, Inc. audit ratification maintains SOX compliance continuity through late 2025. Consistent with a purely procedural corporate action filing, the document advances zero commercial metrics, contains no target valuations, discloses no customer relationships, outlines no technology roadmaps, identifies no market sizing claims, references no pending litigation, and details no sponsorship fee restructuring.

This official exchange action permanently alters the security's trading venue and materially escalates redemption urgency. By formally confirming noncompliance with the 36-month SPAC operating window tied to the May 9, 2022 effective date, Nasdaq has removed any procedural buffer for the sponsor to delay or indefinitely postpone a business combination or extension. Shareholders must now prepare for imminent liquidation procedures and pro rata trust distributions rather than expecting a delayed merger. Liquidity and execution risk spike sharply as the Company warns there may be a very limited market on OTC, no assurance broker-dealers will continue providing public quotes, and trading volume may be insufficient for efficient price discovery. While the Company notes it will remain subject to periodic Exchange Act reporting requirements post-delisting, the mechanical shift to pink sheet trading typically triggers accelerated shareholder redemptions at the stated trust value to prevent permanent capital entrapment.

This is the SPAC's third extension request and comes after massive redemptions ($173M in 2023, $95M in 2024) that have shrunk the trust from ~$267M to ~$18M. The trust per-share value ($12.03) is now only slightly below the trading price ($12.10), creating a tight arbitrage window for holders. The sponsor controls 83.69% of shares and has committed to voting 'for' the extension, effectively guaranteeing approval. For public shareholders, the key decision is whether to redeem now at ~$12.03 or hold for a potential deal, noting that the sponsor has indicated confidence of no further extensions but the board 'may determine to do so in the future'.

Investors monitoring SPAC mechanics should note the auditor transition follows a commercial acquisition rather than a reporting dispute, as confirmed by the absence of disagreements or reportable events, which mitigates immediate sponsor conduct or internal control concerns. However, the explicit going concern qualification attributed to Marcum for the two most recent fiscal years raises tangible liquidity and solvency questions nearly three years out from the IPO, which can intensify shareholder redemption consideration if the business combination does not consummate. The filing confirms redeemable warrants retain an exercise price of $11.50 per share and provides no evidence of extensions, trust value adjustments, or revised deal milestones. Persistent going concern language in a pre-combination SPAC audit typically signals sustained capital allocation challenges that could constrain sponsor operations or trigger early liquidation pathways ahead of the statutory expiration window.

Shareholders must assess the risk of liquidation at $11.87/share by the May 12, 2025 deadline. The deal failure, tiny float, Nasdaq listing risk, and negative net tangible assets increase the probability of liquidation. The trust per-share value ($11.87) is the key redemption benchmark.

The trust value is $12.84 per share, well above $10.00, offering a redemption opportunity. The extension is critical to avoid liquidation and gives the sponsor more time to find a target. The sponsor holds 83.69% of shares and intends to vote for the extension, making approval likely. However, significant redemptions could reduce trust assets and impair ability to close any future deal. Redemption deadline is May 8, 2025. Nasdaq listing rules require completion within 36 months (May 12, 2025), so the extension is necessary to maintain listing.

This instrument establishes a separate May 12, 2025 liquidity deadline for working capital funds, operating independently of the publicly disclosed May 12, 2028 redemption window. The explicit trust waiver shields public shareholder capital from sponsor debt claims, yet the optional conversion mechanism enables the sponsor to transform up to $3,000,000.00 of indebtedness into equity dilution at a fixed $1.00 warrant cost if they elect to do so before maturity. No statements regarding customers, revenue streams, market size, corporate strategy, technology, commercial partnerships, ongoing litigation, or personnel changes appear in the text; the filing contains exclusively structural financing covenants, default remedies tied to bankruptcy or payment failure, New York governing law, and transfer restrictions. The presence of this near-term repayment trigger may influence sponsor patience and public redemption behavior as May 2025 approaches, regardless of the longer-term business combination timeline.

Delisting proceedings could impair liquidity and complicate shareholder voting required for merger approval or extension requests. Management’s governance cure strategy aims to preserve exchange status while the target acquisition proceeds. Additionally, the filing documents security registration details (Units IVCAU, Class A ordinary shares IVCA, and warrants IVCAW exercisable at $11.50 per share), confirms Cayman Islands incorporation (E9), December 31 fiscal year-end (1231), Commission File Number 001-41383, CIK 0001852889, and prior corporate name changes to Investcorp India Acquisition Corp. (February 15, 2022) and Investcorp Acquisition Corp. (March 23, 2021).

Listing maintenance directly governs the tradability and liquidity of the public shares, units, and warrants, which feeds into the broader mechanics of the pending SPAC business combination and the contractual May 12, 2028 merger deadline. Principal Executive Officer and Director Nikhil Kalghatgi disclosed that management intends to actively monitor the MVLS and deploy all reasonable measures to regain compliance within the 180-calendar day window, but explicitly disclaimed any assurance of success. The notice carries no immediate suspension effect on current trading, but sustained non-compliance risks forced delisting or a voluntary transfer to the Nasdaq Capital Market, potentially complicating shareholder voting, sponsor financing, and warrant exercise conditions without directly triggering automatic redemption clauses.

The filing confirms the SPAC has a signed deal with a target (Bigtincan) and a PIPE commitment, but the trust is small ($17.2M) and cash outside trust is minimal. The large redemption (84% of Class A shares) leaves a narrow base. The sponsor's conversion of all Class B shares to Class A before the business combination eliminates the promote structure, which is unusual. The material weakness and going concern qualification are risk factors for shareholders evaluating the deal's likelihood of closing within the extended deadline.

Regarding redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, this late-filing notification does not amend the stated merger completion window, nor does it modify the reported trust balance per share or invoke formal extension mechanisms. However, a disclosed backlog of multiple unfiled historical reports alongside a fresh Rule 12b-25 request signals administrative or accounting processing delays that shareholders monitoring sponsor execution and compliance should track closely, as recurring delays can strain shareholder communication and potentially trigger exchange listing maintenance scrutiny. On other substantive matters, the registrant makes zero claims regarding customers, revenue, market size, strategy, technology, partnerships, or litigation. Mr. Kalghatji explicitly represents that there is no anticipated significant change in results of operations for the pending report, and the document contains no operational metrics or financial figures beyond the procedural timeline commitments.

Shareholders assessing redemption timing can now weigh explicit sponsor co-investment against quantified operational commitments. The documented capital stack, sponsor share retention, and the stated 'rule of 30' incentive framework (revenue growth plus EBITDA margin totaling 30%) establish measurable milestones that management ties to medium-term valuation upside. For investors monitoring trust depletion and extension risks, the filing clarifies that trust outflows will scale directly with redemption requests, while the sponsor’s equity lockup and cash commitments signal alignment with post-combination execution.

By tying the sponsor’s projected 20% ownership stake to a strict mathematical model predicated on 100% public redemptions (minus the sponsor block), the document establishes a transparent baseline for how management anticipates trust utilization, dilution, and post-close equity distribution. The explicit US $12.5 million sponsor commitment and the detailed PIPE parameters reduce ambiguity around closing capital sufficiency, directly informing redemption calculus. The publication of the Hobart AI development initiative, the 'rule of 30' performance targets, and the Nasdaq migration rationale clarifies the strategic trajectory ahead of the definitive proxy statement, allowing investors to cross-reference stated execution goals against current ASX valuations before casting votes.

Shethia indicates these redemption and capital-call assumptions directly determine the trust account liquidation schedule and residual proceeds, establishing whether the combined enterprise can operate on the stated US$37.5 million PIPE without supplementary dilution. The decision for sponsors to withhold 5,500,000 shares from redemption establishes aligned economic exposure tied to Investcorp’s publicly stated goal of delivering approximately 3x private-equity style returns on deployed capital over the medium term. Shethia links this return target operationally to a proposed employee compensation framework labeled the “rule of 30,” which he defines as revenue growth plus EBITDA margin equaling 30%. On operational metrics, Shethia describes Bigtincan as an early artificial intelligence adopter in sales enablement software actively deployed across more than two million user accounts within over 1,000 enterprises, encompassing more than 100 Fortune 500 entities, with over 2,000 global deployments distributed across more than 50 jurisdictions and translated into more than 40 languages. The transaction documentation emphasizes a planned Nasdaq migration to secure broader institutional liquidity and expand commercial reach beyond the current Sydney headquarters and Boston-centric global strategy, targeting client-facing expansion in Tokyo, London, Copenhagen, and the broader United States. Corporate leadership also pledges to establish an AI Technology Development Centre in Hobart, Tasmania, built around existing Bigtincan engineering resources. Shethia forecasts that, following closing, Investcorp will control approximately 20% of the consolidated equity at an effective acquisition cost of roughly A$0.22 per share, presenting the merger as a structural rebasing meant to lift Bigtincan’s valuation multiple away from current Australian exchange baselines toward comparable United States listed peers.

This is the definitive agreement announcement for the proposed business combination. It establishes the legal framework, consideration, and conditions for the deal, which is a critical step for the SPAC and its shareholders. The filing details the exchange ratio, cash election mechanism, and key parties' obligations, which are central to evaluating the transaction's value and likelihood of completion.

This filing establishes the terms of the de-SPAC transaction, setting the exchange ratio and cash alternative, the PIPE backstop, and sponsor conduct (no redemption, warrant vesting, expense cap). Trust per share stands at $12.84, but the PIPE price is $10, implying potential dilution or arbitrage. The cash election provides an exit at $0.16145 per Bigtincan share, but the stock consideration implies a higher value if Pubco shares trade above $10. The deal includes a break fee of $2.75M each way. Investors should monitor redemptions and the cash pool condition. The warrant vesting ties sponsor economics to stock performance. This is the final definitive agreement, so the key terms are locked.

What changed: Amendment No. 1 to Form 8-K/A and Rule 425 written communication filed by Investcorp AI Acquisition Corp. (IVCA) to correct narrative disclosures regarding the Sponsor Support Agreement and detail the executed definitive business combination agreement with Blue Finance Technology Holding Limited. According to the filing, IVCA and Blue Finance signed a business combination agreement on April 8, 2026, structuring a two-step merger through an Irish successor entity (New Pubco) with a stated outside date of November 4, 2026. The agreement dictates that each outstanding IVCA Class A ordinary share will exchange for one New Pubco ordinary share, IVCA Class B shares will automatically convert to Class A immediately prior, and outstanding units will detach into underlying shares and public warrants while all warrants convert to corresponding New Pubco warrants on substantially identical terms. The document states that IVCA’s Sponsor, Samara Special Opportunities, entered a Sponsor Support Agreement committing to vote in favor of the transaction, restrict transfers of its IVCA securities until closing or termination, waive anti-dilution rights, and expressly agree not to redeem its securities for the shareholder vote. The filing confirms closing remains subject to IVCA shareholder approval, effectiveness of a Form F-4 registration statement/proxy-statement prospectus, and conditional Nasdaq Capital Market listing approval. IVCA explicitly notes this amendment does not modify the existing May 12, 2028 redemption deadline. Why it matters: Because IVCA’s Sponsor has contractually pledged to abstain from redemptions and waive anti-dilution protections, the company indicates the public float will experience reduced near-term selling pressure ahead of the shareholder vote. The documented one-to-one share exchange and warrant conversion mechanics establish fixed post-combination ratios before proxy materials route to holders. The confirmed November 4, 2026, outside date sets a definitive horizon for regulatory filings and voting windows, while the unadjusted May 12, 2028, deadline leaves the current liquidation path entirely available to investors. On operational and governance matters, the agreement specifies a five-director Post-Closing Board selected primarily by Blue Finance, with IVCA and The Hugely Successful Company (HSC) retaining deferred nomination rights. The filing further states that Blue Finance’s incumbent Chief Executive Officer and Chief Financial Officer will assume identical leadership titles at New Pubco upon closing. Additionally, the company outlines a five-year, two-tranche contingent earnout mechanism capped at 30,000,000 total shares, payable if New Pubco achieves a $15.00 volume-weighted average price or a $1,000,000,000 market capitalization over ten-of-thirty consecutive trading day measurement periods, providing explicit dilution triggers and allocation frameworks for holders evaluating long-term ownership economics.

What changed: This document is an Information Statement (DEF 14C) filed pursuant to Section 14(c) of the Securities Exchange Act of 1934. In its own terms, it functions as a notice of corporate name change from “Investcorp AI Acquisition Corp.” to “Libity” and a notice extending the business combination deadline, while explicitly stating that no proxy is being solicited and no shareholder vote is legally required under Cayman Islands law. According to the Registrant, the Company extends the date to consummate a business combination from May 12, 2027 to May 12, 2028. The Company specifies that public shareholders may redeem shares at a per-share cash price equal to the aggregate Trust Account balance (including interest, less previously released taxes) divided by then-outstanding public shares. The filing sets a hard mechanical cutoff demanding physical or DTC/DWAC redemption instructions by 5:00 P.M. Eastern Time on May 12, 2026. Annex B, as attached to the filing, further dictates that if a merger is not completed by the Extended Date, the Company must cease operations within 10 business days, redeem shares at the same Trust Account formula price (explicitly subtracting taxes payable and up to US $100,000 of interest for dissolution expenses), and liquidate. The Registrant also confirms an extraordinary general meeting is scheduled for May 14, 2026, where the extension and name change are anticipated to be approved by the Sponsor and two other shareholders representing approximately 99% of voting shares. Why it matters: For investors tracking redemption windows and sponsor conduct, the filing crystallizes a fixed redemption execution window closing at 5:00 P.M. ET on May 12, 2026 and anchors the ultimate liquidation horizon to May 12, 2028. Because the Company asserts that Cayman Islands law permits proceeding without a public proxy solicitation, the governance changes will execute based on consent from the controlling block, insulating management from a direct public referendum on the extended timeline. The Registrant’s ownership table discloses that as of April 28, 2026, there were 6,494,831 ordinary shares outstanding, with Vikas Mittal (acting through Samara Special Opportunities) beneficially owning 65.0% and the former Sponsor, ICE I Holdings Pte. Ltd., holding 29.9%. Beyond these governance mechanics, the proposed rebrand to Libity, and the explicit reservation of up to US $100,000 of interest for dissolution costs, the Company makes no claims regarding target pipeline progress, projected revenues, market size, technology developments, customer partnerships, or litigation status.

What changed: A Form 8-K current report filed by Investcorp AI Acquisition Corp. (IVCA) under Rule 425, announcing the execution of a definitive Business Combination Agreement to combine with Blue Finance Technology Holding Limited. The filing includes the full text of the merger agreement, sponsor support agreement, and related subscription agreements. IVCA announced a definitive business combination with Blue Finance. The consideration to Blue Finance shareholders is 21,985,971 New Pubco ordinary shares with a stated value of $10.00 per share ($219.9mm aggregate). Sponsor Samara Special Opportunities agreed to vote in favor, not redeem, and cancel its 11,261,250 private placement warrants at closing. The outside date is November 4, 2026 (with a hard-stop of December 1, 2026 for closing). The trust is reported to hold at least $486,611.02 as of signing. New Pubco intends to list on Nasdaq Capital Market. Why it matters: This is the first definitive deal agreement for IVCAF, which has a trust per-share value of $12.84 and a deadline of May 12, 2028. Investors should note: (1) the trust value is well above the conventional $10.00 – at $12.84/share the implied redemption pressure could be different than typical SPACs; (2) the sponsor has agreed to not redeem and to cancel its private warrants, which removes a large overhang; (3) the earnout structure is complex and subject to Irish Takeover Rules restructuring risk, with a termination right if parties cannot agree on the earnout structure; (4) the SPAC's securities trade on OTC Markets and the target is going public via an Irish plc structure; (5) FCA approval for change of control is a closing condition, adding a regulatory risk factor not present in domestic deals; (6) Blue Finance is an AI-driven UK consumer lender having originated over $200 million in loans.

What changed: 8-K: Entry into a Material Definitive Agreement (Business Combination Agreement with Blue Finance Technology Holding Limited). IVCA (Investcorp AI Acquisition Corp.) signed a definitive Business Combination Agreement with Blue Finance Technology Holding Limited, an Irish digital finance company. The deal involves a two-step structure: (1) Blue Finance shareholders contribute all their shares to New Pubco (Irish Holdco) in exchange for 21,985,971 New Pubco ordinary shares at a stated value of $10.00 per share ($219.9M aggregate); (2) Merger Sub merges with and into IVCA, with IVCA surviving as a wholly owned subsidiary of New Pubco. Each IVCA public share is exchanged for one New Pubco ordinary share, and each IVCA warrant is converted into a New Pubco warrant exercisable at $11.50 per share. Additional issuances: 814,029 New Pubco shares to HSC (The Hugely Successful Company, LLC) and 1,200,000 shares to MFC Tech Limited, both at $0.0001 per share. Earnout of up to 6,000,000 shares in two tranches: 3M shares at $15 VWAP and 3M shares at $1B market cap, over five years. Total share cap across all issuances is 30,000,000 shares. Sponsor Samara Special Opportunities agreed to vote in favor, not redeem its shares, waive anti-dilution rights, and cancel all 11,261,250 private placement warrants at closing. The sponsor also agreed to a lock-up on transfers until closing. The trust account holds at least $486,611.02 as of the agreement date; trust per share is $12.84. The outside date for closing is November 4, 2026, with a specific termination if not closed by December 1, 2026. Conditions include SPAC shareholder approval, Irish regulatory approvals, FCA change-of-control approval, effectiveness of Form F-4, Nasdaq listing, and Irish tax confirmations. The deal is structured as a Section 351 exchange for U.S. tax purposes. Why it matters: This is the definitive deal announcement for IVCA. Key for investors: (1) Redemption risk — public shareholders can redeem at the closing; trust per share is $12.84, above the $10.00 stated value, so there is potential for redemptions. Sponsor has agreed not to redeem and to cancel its private warrants, which is a positive signal and reduces dilution. (2) Target — Blue Finance is a UK-based digital lender (My Finance Club) with FCA authorization, requiring regulatory approval, which adds execution risk. (3) Structure — New Pubco will be an Irish public company listed on Nasdaq, so there are Irish corporate and tax complexities. (4) Earnout — performance-based shares up to 6M shares, which could drive additional dilution if milestones are met. (5) Sponsor conduct — sponsor agreed to cancel all private warrants (11.26M), which is a significant concession and aligns interests. (6) Deadline — the 2028 deadline is unusually long, likely from prior extensions; the deal has a firm outside date of November 4, 2026, and a hard drop-dead of December 1, 2026. (7) Trust value — $12.84/share is above the $10 stated value, so there may be incentive for redemptions. (8) Financials — Blue Finance's unaudited financials show 2025/2024 data; no PCAOB audited statements yet, but the agreement requires audited 2024 financials by April 30, 2026 and 2025 by May 31, 2026, which are conditions precedent.

What changed: SC 14F-1 Information Statement: Notice of Change in Majority of Board of Directors and Control following a Share Purchase Agreement. On August 28, 2025, ICE I Holdings Pte. Ltd. (the 'Sponsor') and company insiders ('Sellers') entered into a Purchase Agreement with Samara Special Opportunities ('Buyer') which closed on the same date. Pursuant to the Agreement, the Buyer acquired 4,528,124 Class A ordinary shares, 11,261,250 private placement warrants, and one Class B ordinary share from the Sellers. As a result, the Buyer holds 4,528,124 Class A shares (representing 69.7% of the issued and outstanding Class A shares) and one Class B share (100% of voting control), effectively transferring majority control to the Buyer and its principal, Vikas Mittal. The Sponsor (ICE I Holdings) retained record holding of 1,940,626 Class A shares, representing 29.9% ownership. Concurrent with the closing, Vikas Mittal was designated as a new director and appointed Principal Executive Officer, replacing Nikhil Kalghatgi. James DeAngelis was designated as a new director and appointed Principal Financial Officer, replacing Dean Clinton. Directors Nikhil Kalghatgi, Dean Clinton, Rishi Kapoor, Kunal Bahl, Girish Vanvari, Ashwini Asokan, and Manpreet Singh tendered resignations effective ten days following the filing and mailing of this statement. The Board designates both Mittal and DeAngelis as new directors, although the Agreement text notes the Board may consist of one director pending succession. Why it matters: This filing documents a third-party take-control transaction that fundamentally alters the SPAC's trajectory and sponsor dynamics. The acquisition of 69.7% of public shares by Samara Special Opportunities/Vikas Mitta suggests a concentrated shareholder base that can exert significant pressure on management regarding business combination strategy or redemption outcomes. The resignation of the entire incumbent board removes the previous Investcorp-affiliated leadership structure. Financial disclosures reveal heavy reliance on sponsor funding and extensions: outstanding working capital loans totaled $2,836,172 as of June 30, 2025, and extension contribution notes reached a principal balance of $1,650,000 by the same date. Subsequent to June 30, 2025, the Company satisfied approximately $6.2 million in liabilities, including a $4.9 million write-off of liabilities owed to the Sponsor. These figures indicate extensive liquidity support and potential forgiveness to keep the entity solvent. The extension notes are payable no earlier than May 12, 2027, confirming an extended timeline past the original period. Governance risks persist as the Company maintains no audit, nominating, or compensation committees due to its OTC Pink listing status, leaving all board functions to the directors. No business combination target is identified in this filing.

What changed: A Form 8-K current report and accompanying Purchase Agreement disclosing the transfer of sponsor-controlled securities, full board and officer resignations, and associated corporate governance adjustments. According to the Purchase Agreement, on August 28, 2025, Sponsor ICE I Holdings Pte. Ltd. sold to Acquirer Samara Special Opportunities one Class B ordinary share, 4,528,124 Class A ordinary shares, and 11,261,250 private placement warrants for an aggregate purchase price of $1.00. The filing notes that effective on the Closing Date, Nikhil Kalghatgi and Dean Clinton resigned as officers and were replaced by Vikas Mittal (Principal Executive Officer) and James DeAngelis (Principal Financial Officer). The Recitals report the SPAC’s contractual lifespan expires on May 12, 2027. Section 4 acknowledges Sponsor will retain 1,940,625 Class A shares and 4,826,500 warrants, which may not be transferred until a business combination closes. The agreement assigns all future SPAC operating costs and any trust account extension funding to Acquirer, while leaving pre-August 28, 2025 liabilities with Sponsor. Within 60 days, the Acquirer must convene a shareholder meeting to remove “Investcorp” from the company name. The document confirms the SPAC was delisted from Nasdaq and trades on the OTC Markets – Pink Sheets, cites historical sponsor costs of $25,000 ($0.0035 per converted Class A share) and $16,087,500 ($1.00 per warrant), and caps tail D&O insurance at 150% of the current premium for six years of coverage. An August 29, 2025 Payment Date governs final liability reconciliations, and Section 16 sets a hard termination deadline of September 1, 2025 if conditions remain unsatisfied. Why it matters: Because the Purchase Agreement transfers control for $1.00 before any business combination announcement, future redemption votes, extension approvals, and trust fund usage are now directed by the Acquirer rather than the founding sponsor. The explicit waiver in Section 14(c) stating the Acquirer assumes liquidation risk and the Seller forfeits claims related to failed combinations fundamentally alters the traditional redemption-calculus and sponsor conduct landscape. The compressed September 1, 2025 termination window starkly contrasts with the May 12, 2027 contractual deadline, pressuring rapid deal execution or alternative liquidity arrangements. Sponsor retention of over 1.9 million shares and nearly 4.8 million warrants without matching forfeiture safeguards preserves significant post-combination equity upside for the original sponsor, potentially influencing voting dynamics. With no trust balance disclosed and all ongoing administrative, legal, and accounting expenses mandated to be funded by the Acquirer, shareholders must reassess baseline redemption expectations and monitor the incoming board’s integration timeline, registration rights joinder, and upcoming name-change vote for further mechanical triggers.

What changed: Quarterly Report on Form 10-Q for the period ended June 30, 2025. The Company held the 2025 extraordinary general meeting on May 12, 2025, where shareholders approved a further extension of the business combination deadline from May 12, 2025 to May 12, 2027. In connection with this meeting, holders of 1,449,359 Class A ordinary shares exercised their redemption rights at approximately $12.09 per share, resulting in aggregate redemptions of approximately $17,521,050. Following this redemption, the trust account balance fell to $473,146 (26,021 shares at $18.18 per share) as of June 30, 2025, down from $17,518,993 (1,475,380 shares at $11.87 per share) at December 31, 2024. The Company also noted that it was delisted from Nasdaq and its securities began trading on OTC Markets in May 2025. Why it matters: This filing confirms that IVCAF has secured a two-year extension to its deadline, but at the cost of near-total redemptions: only 26,021 of the initial 1,475,380 shares remained in trust as of June 30, 2025. With a trust account of less than $500,000 and a reported working capital deficit, the SPAC is effectively stripped of the capital needed to complete an acquisition. The Company disclosed a material weakness in internal controls and raised substantial doubt about its ability to continue as a going concern. The delisting to OTC Markets further limits the potential for a business combination.

What changed: A Delisting Determination from The Nasdaq Stock Market, LLC, dated July 11, 2025. According to The Nasdaq Stock Market, LLC, Nasdaq Staff determined the Company no longer qualified for listing pursuant to Listing Rule IM-5101-2(b), notifying the Company on April 29, 2025. Nasdaq Staff confirmed the Company did not file an appeal, the securities were suspended, and the determination became final on May 8, 2025, with formal removal effective at the opening of the trading session on July 24, 2025. This terminates exchange listing mechanics without modifying the reported $12.84 trust/share balance, the 2028-05-12 deadline, or any redemption triggers. As stated by The Nasdaq Stock Market, LLC, the filing contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: Per The Nasdaq Stock Market, LLC's determinations, stripping Nasdaq listing status during an active business combination phase forces secondary trading to alternative venues, which typically thickens bid-ask spreads and delays execution around any redemption or conversion windows. Because the Exchange tied the action to Listing Rule IM-5101-2(b) rather than a failed transaction, shareholder liquidity is restricted pending resolution of the announced deal or expiration of the 2028-05-12 deadline, compounding uncertainty around trust preservation and exit timing.

What changed: A Form 8-K Current Report (Items 5.07 and 9.01) recording the procedural outcomes of a virtual Extraordinary General Meeting convened on May 12, 2025, alongside the electronic submission of Exhibit 3.1, which houses the executed Amendment to the Amended and Restated Memorandum and Articles of Association. According to the registrant’s filing, the Extraordinary General Meeting approved the Extension Amendment Proposal, contractually shifting the mandatory business combination deadline from May 12, 2025 to May 12, 2027, with a finalized count of 6,938,190 votes for, 157,419 against, and 0 abstentions. In direct consequence of that extension vote, holders of 1,449,359 Class A ordinary shares exercised their redemption rights at a stated price of approximately $12.09 per share, producing an aggregate trust distribution of approximately $17,521,050. The filing documents that 7,095,609 Class A and Class B ordinary shares were present or represented as of the April 28, 2025 record date, representing 89.32% of outstanding stock. Separate proposals carried the election of Rishi Kapoor (6,939,757 for / 150,000 withheld) and Kunal Bahl (6,945,609 for / 150,000 withheld) to Class I director positions for three-year terms expiring at the 2028 Annual Meeting, alongside the ratification of CBIZ, Inc. as independent auditor for the fiscal year ending December 31, 2025 (6,945,609 for / 150,000 against). A scheduled adjournment motion was explicitly marked as not acted upon. Exhibit 3.1 legally enforces the change by deleting the original May 12, 2025 operative language in Article 36.2 and substituting the May 12, 2027 timeframe. Why it matters: Per the disclosed mechanics, securing a twenty-four-month extension immediately removes the imminent liquidation clock, granting the sponsor and management team additional operational runway to identify, negotiate, and close a qualifying target without triggering automatic trust dissolution. The documented $17,521,050 redemption outflow permanently reduces remaining net asset value, tightening future liquidity parameters for warrant exercises, working capital needs, or fund financing relative to pre-vote balances. Near-universal proxy engagement (89.32%) and a decisive shareholder majority indicate robust institutional and retail consensus behind the continuation strategy rather than a flight-to-cash revolt. The Kapoor and Bahl director appointments reflect routine board rotation rather than strategic leadership overhauls, while the CBIZ, Inc. audit ratification maintains SOX compliance continuity through late 2025. Consistent with a purely procedural corporate action filing, the document advances zero commercial metrics, contains no target valuations, discloses no customer relationships, outlines no technology roadmaps, identifies no market sizing claims, references no pending litigation, and details no sponsorship fee restructuring.

What changed: Quarterly report on Form 10-Q for the period ended March 31, 2025, for Investcorp AI Acquisition Corp (IVCAF). Subsequent to quarter end, on May 12, 2025, shareholders approved extending the business combination deadline from May 12, 2025 to May 12, 2027. At that meeting, holders of 1,449,359 Class A shares (98.2% of the 1,475,380 then-outstanding redeemable shares) redeemed at ~$12.09 per share, reducing public shares to approximately 26,021. The trust account held $17,852,573 ($12.10 per share) at March 31, 2025, implying the trust will be depleted to roughly $0.3 million post-redemption. On April 29, 2025, Nasdaq notified the company of delisting under Rule IM-5101-2, and trading moved to OTC Markets on May 6, 2025. The company also reported a going concern doubt, a working capital deficit of $4.5 million, and a material weakness in internal controls. Why it matters: The near-total redemption of public shares and Nasdaq delisting fundamentally alter the SPAC's prospects. With only ~26,000 public shares remaining and trust proceeds essentially gone, the sponsor (ICE I Holdings) now controls virtually all voting power through its 6,468,749 Class A (converted from Class B) shares. The company will struggle to attract a target without meaningful cash in trust and with reduced market visibility on OTC. The extension to 2027 provides time, but the economics of any potential deal would rely almost entirely on sponsor equity or new financing. The delisting heightens risk of further liquidity deterioration. Investors face heightened risk of liquidation if no business combination is consummated.